Emtricitabine

(Difference between revisions)

Revision as of 10:53, 29 March 2023

Revision as of 10:46, 29 March 2023 (edit) Alexander Berchansky (Talk \| contribs) (New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[...) ← Previous diff		Revision as of 10:53, 29 March 2023 (edit) (undo) Alexander Berchansky (Talk \| contribs) Next diff →
Line 1:		Line 1:
-	<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''>	+	<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/959998/Cv/1'>
	Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[1]), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children.		Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[1]), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children.